Cooperating conferences
4th DNA Repair/Replication Structures and Cancer Conference
Time and Venue: 16 Feb 2020 - 20 Feb 2020; Nassau, Bahamas.
About: The 4th DNA Repair/Replication Structures & Cancer conference in February 2020 will focus on structural and mechanistic insights into dynamic protein, chromatin, DNA and RNA complexes acting in DNA repair and its interface with DNA replication and transcription events relevant to cancer. This fundamental information will be pivotal for the accurate interpretation of cancer clinical data, design of clinical trials, prognosis, etiology and improving the currently 1/20 low success rate for oncology drug clinical trials. Informative talks and poster sessions along with vibrant discussions will foster productive interactions and collaborations.
2nd Epigenetics Conference
Time and Venue: 28 Feb 2020 - 02 Mar 2020; Nassau, Bahamas.
About: This meeting aims to present the most recent advances in the mechanistic understanding of DNA metabolic processes at the single-molecule level, using both in vivo and in vitro approaches. The conference will appeal to PhD students, post-doc and group leaders working in the field of chromatin architecture, epigenetics, stem cell biology and cancer along with scientists active in R&D of small, medium and big pharma or biotech companies.
2nd Neuroepigenetics & Neuroepitranscriptomics Conference
Time and Venue: 03 Mar 2020 - 06 Mar 2020; Nassau, Bahamas.
About: This meeting will bring together experts and pioneers studying neuroepigenetics and epitranscriptomics to provide an up-to-date and comprehensive picture of epigenetic and epitranscriptomic mechanisms in neural development, reprogramming and cell identity, plasticity, neuronal function and dysfunction.
3rd Chromosomal Instability as a Driver of Human Disease Conference
Time and Venue: 05 Oct 2020 - 08 Oct 2020; Lisbon, Portugal.
About: This meeting will appeal to Molecular/Cell Biologists/Geneticists & Biochemists interested in genome stability. Researchers interested in the molecular basis of cancer, neurodegenerative diseases and ageing and those with an interest in high throughput genetic and pharmacological screening methods.